Geode Capital Management
PGEN icon

Geode Capital Management’s Precigen PGEN Stock Holding History

Geode Capital Management’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.6M Buy
5,019,028
+405,599
+9% +$1.75M ﹤0.01% 1954
2026
Q1 		$17.9M Buy
4,613,429
+151,351
+3% +$621K ﹤0.01% 2055
2025
Q4 		$18.7M Buy
4,462,078
+613,340
+16% +$2.37M ﹤0.01% 2045
2025
Q3 		$12.7M Buy
3,848,738
+99,556
+3% +$281K ﹤0.01% 2274
2025
Q2 		$5.32M Buy
3,749,182
+269,580
+8% +$383K ﹤0.01% 2699
2025
Q1 		$5.19M Buy
3,479,602
+179,751
+5% +$283K ﹤0.01% 2633
2024
Q4 		$3.7M Buy
3,299,851
+53,343
+2% +$45.5K ﹤0.01% 2887
2024
Q3 		$3.08M Buy
3,246,508
+149,829
+5% +$189K ﹤0.01% 2977
2024
Q2 		$4.89M Buy
3,096,679
+65,794
+2% +$95.5K ﹤0.01% 2736
2024
Q1 		$4.4M Buy
3,030,885
+9,588
+0.3% +$13.8K ﹤0.01% 2765
2023
Q4 		$4.05M Buy
3,021,297
+110,042
+4% +$129K ﹤0.01% 2814
2023
Q3 		$4.13M Buy
2,911,255
+35,065
+1% +$49.7K ﹤0.01% 2738
2023
Q2 		$3.31M Buy
2,876,190
+238,524
+9% +$282K ﹤0.01% 2917
2023
Q1 		$2.8M Buy
2,637,666
+745,952
+39% +$1.08M ﹤0.01% 2892
2022
Q4 		$2.88M Buy
1,891,714
+22,342
+1% +$38.4K ﹤0.01% 2918
2022
Q3 		$3.96M Buy
1,869,372
+147,700
+9% +$311K ﹤0.01% 2791
2022
Q2 		$2.31M Sell
1,721,672
-6,888
-0.4% -$10.2K ﹤0.01% 3062
2022
Q1 		$3.65M Sell
1,728,560
-29,112
-2% -$70.9K ﹤0.01% 2964
2021
Q4 		$6.52M Buy
1,757,672
+191,386
+12% +$824K ﹤0.01% 2734
2021
Q3 		$7.82M Sell
1,566,286
-259,149
-14% -$1.49M ﹤0.01% 2643
2021
Q2 		$11.9M Buy
1,825,435
+334,776
+22% +$2.34M ﹤0.01% 2340
2021
Q1 		$10.3M Buy
1,490,659
+330,320
+28% +$2.79M ﹤0.01% 2344
2020
Q4 		$11.8M Buy
1,160,339
+118,847
+11% +$770K ﹤0.01% 2053
2020
Q3 		$3.65M Sell
1,041,492
-90,709
-8% -$431K ﹤0.01% 2572
2020
Q2 		$5.65M Sell
1,132,201
-34,172
-3% -$116K ﹤0.01% 2266
2020
Q1 		$3.96M Buy
1,166,373
+91,938
+9% +$397K ﹤0.01% 2272
2019
Q4 		$5.89M Buy
1,074,435
+12,031
+1% +$67.7K ﹤0.01% 2347
2019
Q3 		$6.08M Buy
1,062,404
+29,246
+3% +$199K ﹤0.01% 2263
2019
Q2 		$7.91M Buy
1,033,158
+137,379
+15% +$740K ﹤0.01% 2101
2019
Q1 		$4.71M Buy
895,779
+72,631
+9% +$504K ﹤0.01% 2372
2018
Q4 		$5.38M Buy
823,148
+56,831
+7% +$637K ﹤0.01% 2176
2018
Q3 		$13.2M Buy
766,317
+137,226
+22% +$2.04M ﹤0.01% 1719
2018
Q2 		$8.77M Buy
629,091
+89,103
+17% +$1.5M ﹤0.01% 1973
2018
Q1 		$8.28M Buy
539,988
+41,280
+8% +$590K ﹤0.01% 1900
2017
Q4 		$5.74M Buy
498,708
+12,847
+3% +$191K ﹤0.01% 2130
2017
Q3 		$9.24M Buy
485,861
+16,502
+4% +$340K ﹤0.01% 1788
2017
Q2 		$11.3M Buy
469,359
+39,827
+9% +$873K ﹤0.01% 1572
2017
Q1 		$8.51M Buy
429,532
+10,940
+3% +$244K ﹤0.01% 1726
2016
Q4 		$10.1M Buy
418,592
+41,916
+11% +$1.17M ﹤0.01% 1570
2016
Q3 		$10.5M Buy
376,676
+58,837
+19% +$1.56M 0.01% 1463
2016
Q2 		$7.75M Buy
317,839
+15,717
+5% +$446K ﹤0.01% 1624
2016
Q1 		$10.1M Buy
302,122
+6,605
+2% +$208K 0.01% 1388
2015
Q4 		$8.83M Buy
295,517
+13,061
+5% +$440K 0.01% 1458
2015
Q3 		$8.9M Buy
282,456
+62,947
+29% +$3.07M 0.01% 1428
2015
Q2 		$10.6M Sell
219,509
-12,091
-5% -$510K 0.01% 1379
2015
Q1 		$10M Buy
231,600
+15,635
+7% +$562K 0.01% 1391
2014
Q4 		$5.68M Buy
215,965
+54,353
+34% +$1.19M ﹤0.01% 1734
2014
Q3 		$2.87M Buy
161,612
+81,800
+102% +$1.67M ﹤0.01% 2140
2014
Q2 		$1.92M Buy
79,812
+14,708
+23% +$298K ﹤0.01% 2388
2014
Q1 		$1.64M Buy
65,104
+4,881
+8% +$135K ﹤0.01% 2460
2013
Q4 		$1.37M Buy
60,223
+894
+2% +$18.1K ﹤0.01% 2521
2013
Q3 		$1.34M Buy
+59,329
New +$1.37M ﹤0.01% 2421

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return

Geode Capital Management's PGEN Position: Q2 2026 in Review

Geode Capital Management increased its Precigen (PGEN) stake by 8.8% in Q2 2026, buying an estimated $1.75M and bringing the position to 5,019,028 shares worth $28.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1954.

Geode Capital Management first reported a position in PGEN in Q3 2013 and has held it in 52 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Geode Capital Management held 5,019,028 shares of Precigen worth $28.6M as of Q2 2026.
  • Geode Capital Management bought 405,599 Precigen shares in Q2 2026, an estimated $1.75M.
  • Precigen made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #1954 holding.
  • Geode Capital Management first reported a position in Precigen in Q3 2013 and has held it in 52 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.